Activation of heterodimeric () integrin is crucial for regulating cell adhesion. Binding of talin to the cytoplasmic face of integrin activates the receptor, but how integrin is maintained in a resting state to counterbalance its activation has remained obscure. Here, we report the structure of the cytoplasmic domain of human integrin  IIb  3 bound to its inhibitor, the immunoglobin repeat 21 of filamin A (FLNa-Ig21). The structure reveals an unexpected ternary complex in which FLNa-Ig21 not only binds to the C terminus of the integrin  3 cytoplasmic tail (CT), as previously predicted, but also engages N-terminal helices of  IIb and  3 CTs to stabilize an inter-CT clasp that helps restrain the integrin in a resting state. Combined with functional data, the structure reveals a new mechanism of filamin-mediated retention of inactive integrin, suggesting a new framework for understanding regulation of integrin activation and adhesion.
a r t i c l e s Integrins are a family of major cell-surface receptors that mediate numerous life processes by orchestrating adhesion of cells to the extracellular matrix (ECM) and promoting many dynamic celladhesion processes such as migration, spreading and survival 1 . Integrins are obligate (αβ) heterodimers with each subunit composed of a large ligand-binding domain (ectodomain), a single transmembrane domain and a short CT. Integrins can exist in either a resting or an active state, with the latter being capable of binding to the ECM and triggering cell-ECM adhesion. The resting-state integrin is often described as a 'naked' form, which may bind integrin activators, such as talin, and then convert into the active state via conformational change 1, 2 . However, recent studies have suggested that a more complex mechanism can exist in which critical intracellular integrin inactivators may mediate integrin deactivation or retention of the inactive receptor during cyclical cell-adhesion processes such as migration (reviewed in ref. 3 ). The underlying molecular basis for how the inactivators engage integrin to control the dynamic equilibrium between the resting and active states of the receptor has remained elusive. One widely proposed mechanism is competition between inactivator and activator for binding to an overlapping binding site on the integrin CT 2,3 . For example, filamin was shown to compete with talin for binding to an overlapping site at the integrin β CT C terminus 4 . It has also been proposed that an inactivator may engage the inactive state of integrin 3 , but no atomic-level information is available as to how such an interaction occurs and inhibits integrin activation.
The focus of this study is on the integrin inactivator filamin, a large (280 kDa) actin cross-linking protein that is known to regulate the cytoskeleton and many dynamic cell-adhesion responses including cell migration, spreading and proliferation 5 . Filamin contains two N-terminal actin-binding domains followed by 24 contiguous immunoglobulin (Ig)-like repeats that engage many protein binding partners. The filamin Ig repeat 21 was previously shown to bind integrin and inhibit receptor activation 4, 6, 7 . Consistently with this, ablation or decreased expression of filamin was found to enhance integrinmediated cell-substrate adhesion in multiple cell lines 4, 6, [8] [9] [10] , whereas strengthened filamin-integrin interaction inhibits integrin-ligand interaction and cell migration 11 . Here, using NMR spectroscopy, we set out to determine the solution structure of the platelet integrin α IIb β 3 cytoplasmic domain bound to FLNa-Ig21. Surprisingly, the structure reveals a ternary complex in which FLNa-Ig21 not only binds the previously predicted C-terminal site of the integrin β 3 CT, which was thought to block talin binding, but also engages two N-terminal helices of α IIb and β 3 CTs, thus stabilizing an inter-CT clasp that helps to restrain the integrin in a resting state. The results reveal a new mechanism of filamin-mediated retention of integrin at a resting state. They also provide a new framework for understanding the dynamic regulation of integrin activation crucial for mediating diverse cell adhesion-dependent physiological and pathological processes.
RESULTS

FLNa-Ig21 binds to both integrin  IIb and  3 CTs
Previous studies have shown that filamin recognizes the C terminus of integrin β CTs 4, 8, 11, 12 . However, a detailed structural characterization of how filamin may engage the complete integrin cytoplasmic face has not been reported, to our knowledge. To address this issue, we decided to use NMR to analyze filamin A binding to α IIb β 3 , the prototypic integrin whose CT complex has been characterized before 13 . We first performed an HSQC experiment to examine the binding of FLNa-Ig21 to 15 N-labeled β 3 CT K716-T762 ( Fig. 1a) . As expected, FLNa-Ig21 induced chemical-shift changes of the C-terminal integrin β 3 CT (β 3 -C). However, surprisingly, FLNa-Ig21 also induced spectral perturbation (line broadening) of the N-terminal membrane-proximal region of β 3 CT (β 3 -MP), thus suggesting that FLNa-Ig21 binds not only to β 3 -C but also to β 3 -MP. To further a r t i c l e s investigate this unexpected binding mode, we designed a construct containing β 3 -MP (K716-W739, β 3 -N) but lacking β 3 -C. Purified 15 Nlabeled β 3 -N indeed bound to FLNa-Ig21 ( Supplementary Fig. 1a ). Surface plasmon resonance (SPR) experiments revealed a K d ≈ 223 µM ( Supplementary Fig. 1b ). Consistently with this, SPR experiments also produced sensorgrams of full-length β 3 CT binding to FLNa-Ig21 that could fit into a two-site binding model with K d1 ≈ 4.9 µM and K d2 ≈ 150 µM (Fig. 1b) . The latter may correspond to the β 3 -N-FLNa-Ig21 interaction ( Supplementary Fig. 1b ), whereas the former may reflect the β 3 -C-FLNa-Ig21 interaction. This two-site binding mode is remarkably reminiscent of the integrin activator talin-F3 binding to the integrin β CT [13] [14] [15] , yet FLNa-Ig21 and talin-F3 have completely opposite effects on integrin activation 2,3 . β 3 -N, when bound to FLNa-Ig21, exhibits a helical conformation, thus suggesting that while β 3 -C occupies the known groove of the C and D strands (CD groove) of FLNa-Ig21 to form a β-sheet 4,8 , the β 3 -N helix may dock onto FLNa-Ig21 in a different and nonexclusive mode ( Supplementary  Fig. 1c ). To gain more definitive evidence for this binding mode, we designed a FLNa-Ig21-β 3 -C chimera on the basis of the crystal structure of the FLNa-Ig21-β 7 -C complex (PDB 2BRQ; details in Online Methods). This construct allows β 3 -C to tightly occupy the CD groove of FLNa-Ig21 as the strand (confirmed in Supplementary  Fig. 1d ) that would prevent potential displacement by β 3 -N if the two β 3 CT fragments were to bind to FLNa-Ig21 in a mutually exclusive manner. β 3 -N, which binds to FLNa-Ig21 weakly, still induced npg a r t i c l e s chemical-shift changes of FLNa-Ig21 in the 15 N-labeled FLNa-Ig21β 3 -C chimera, thus providing strong evidence that β 3 -C and β 3 -N bind to FLNa-Ig21 in a nonexclusive manner ( Supplementary Fig. 1e ).
Given that FLNa-Ig21 engages inactive integrin 4, 6 , in which α IIb CT and β 3 CT associate to form a clasp 13, 16 , these findings led us to wonder whether FLNa-Ig21, while binding to β 3 CT, might also interact with α IIb CT. Interestingly, both NMR ( Fig. 1c) and SPR ( Fig. 1d ) experiments showed that FLNa-Ig21 binds to α IIb CT with a K d ≈ 229 µM. Like β 3 -N, the FLNa-Ig21-bound α IIb CT also adopts a helical conformation in its N-terminal region ( Supplementary Fig. 1f,g) .
FLNa-Ig21 stabilizes the  IIb CT- 3 CT complex
The binding of FLNa-Ig21 to both α IIb and β 3 CTs suggests formation of a ternary complex. To examine this possibility, we performed a series of independent binding experiments. Pulldown experiments ( Fig. 2a and Supplementary Data Set 1) showed that whereas β 3 CT fused to maltose-binding protein failed to pull down α IIb CT, owing to low affinity (K d ≈ 368 µM for the α IIb CT-β 3 CT complex; Supplementary Fig. 2a ), it was able to pull down α IIb CT in the presence of FLNa-Ig21. SPR experiments ( Fig. 2b) showed that α IIb CT could readily bind to FLNa-Ig21-presaturated β 3 CT. NMR experiments ( Fig. 2c) showed that whereas FLNa-Ig21 induced chemical-shift changes of 15 N-labeled α IIb CT, addition of β 3 -N induced more spectral changes, results indicative of an additional binding event.
To more definitively confirm the formation of the ternary complex, we designed an FLNa-Ig21-β 3 CT chimera construct as we did for FLNa-Ig21-β 3 -C ( Supplementary Fig. 1d ), so that the β 3 CT bound tightly to FLNa-Ig21. As expected, this FLNa-Ig21-β 3 CT chimera still retained the capacity to bind to α IIb CT ( Fig. 2d) , thus indicating that β 3 CT and α IIb CT bind to two distinct regions in FLNa-Ig21. Pulldown experiments further demonstrated that α IIb CT exhibited stronger binding to the FLNa-Ig21-β 3 CT chimera than to FLNa-Ig21 ( Fig. 2e) . Correspondingly, SPR experiments revealed K d values of ~19 µM for the former (Fig. 2f ) and ~229 µM for the latter (Fig. 1d) . The increased affinity is obviously due to the ternary binding of α IIb CT to FLNa-Ig21 and β 3 CT, respectively. Overall, these data indicated that FLNa-Ig21 promotes α IIb CT-β 3 CT complex formation.
Structure of FLNa-Ig21- IIb CT- 3 CT ternary complex
To obtain a definitive three-dimensional (3D) atomic view of how FLNa-Ig21 engages both α IIb CT and β 3 CT, we set out to solve the total structure of the ternary complex. β 3 CT has low solubility 13 and substantial line-broadening problems upon binding to FLNa-Ig21 ( Fig. 1a) . We therefore screened β 3 CT mutants and found that a L717K L718K mutant exhibited substantially less line broadening yet maintained high solubility without affecting the binding of FLNa-Ig21 ( Supplementary Fig. 2b,c) and still promoted ternary-complex formation (Supplementary Fig. 2d ). We carried out an array of NMRbased heteronuclear and homonuclear experiments for resonance and NOE assignments of the ternary complex (Online Methods). We first defined complex interfaces by definitive intermolecular NOEs (Supplementary Fig. 2e ) and chemical shift-mapping data, and further validated them by mutagenesis data ( Supplementary Table 1 ; superposition of the 20 lowest-energy structures in Fig. 3a ; statistics in Table 1 ). FLNa-Ig21 adopts the canonical Ig fold (Fig. 3b) , as previously reported 4, 7, 8 . However, interestingly, although the CD groove of FLNa-Ig21 binds canonically to β 3 -C Y747 F754 as a strand, an extended surface involving the N-terminal short helix, BC loop, C strand and FG loop grabs both the α IIb -N and β 3 -N helix, thus supporting the formation of an α IIb -N-β 3 -N helical clasp ( Fig. 3b ; critical interface residues involved in the FLNa-Ig21-α IIb -N-β 3 -N network in Fig. 3c and Supplementary Fig. 3 ). From α IIb CT to FLNa-Ig21, the interactions are predominantly hydrophilic, including several potential hydrogen-bond and salt-bridge pairs between the α IIb W988 backbone and the FLNa-Ig21 N2312 side chain CONH 2 ; the α IIb K994 NH 3 + and the E2313 backbone carbonyl group; the α IIb R995 backbone carbonyl group and the FLNa-Ig21 E2313 carboxyl group; and the α IIb R997 guanidyl group and the FLNa-Ig21 E2276 npg a r t i c l e s carboxyl group. From β 3 CT to FLNa-Ig21, the β 3 -N helix uses I719 and T720 Cβ H and Cγ H 3 to form a hydrophobic core with FLNa-Ig21 A2268, whereas the β 3 T720 hydroxyl Cβ OH group forms a potential hydrogen bond with the backbone amide of FLNa-Ig21 G2269. These contacts properly orient the α IIb -N and β 3 -N helices to form an interhelical clasp involving a hydrophobic contact between α IIb W988 and β 3 I719; a potential hydrogen bond between the α IIb R995 guanidyl group and the T720 Cβ OH; and a salt bridge between α IIb R995 and β 3 D723. This salt bridge has been widely presumed to be crucial for restraining the resting integrins 13, 16 . The specific FLNa-Ig21 interfaces with α IIb CT and β 3 CT are consistent with extensive mutagenesis data (Supplementary Table 1) . Notably, the FLNa-Ig21 E2276A mutation, while retaining the binary FLNa-Ig21-β 3 CT interaction, disrupted the FLNa-Ig21-α IIb CT interaction ( Supplementary Fig. 4a,b) . Also, the α IIb CT K994E R997E mutation abolished α IIb CT binding to wild-type (WT) FLNa-Ig21 (Supplementary Fig. 4c ) without disrupting the α IIb CT-β 3 CT interface ( Fig. 3c and Supplementary Fig. 4d ). FLNa-Ig21 A2268K specifically disrupted the FLNa-Ig21 interaction with β 3 -N while retaining the binary FLNa-Ig21 binding to α IIb CT (Supplementary Fig. 4e,f) .
FLNa-Ig21 promotes  IIb  3 transmembrane heterodimerization
Examination of the structure of the FLNa-Ig21-α IIb β 3 CT complex reveals that FLNa-Ig21 would be situated near the juxtatransmembrane region when bound to the integrin CT clasp (Fig. 4a) . In support of this prediction, we found that FLNa-Ig21 binds weakly to large unilamellar vesicles (LUVs), as judged by small chemical-shift changes of H2239, K2240 and R2242 (Fig. 4b,c) . These residues form a positively charged surface with the integrin transmembrane border residues α IIb CT K989 and β 3 CT K716, providing a topology allowing engagement of FLNa-Ig21 with the membrane-proximal regions of α IIb β 3 on the membrane surface ( Fig. 4a) . To further examine how filamin may engage integrin in a membrane environment, we performed an HSQC experiment with 15 N-labeled α IIb transmembrane-cytoplasmic domain (TMCD) bound to unlabeled β 3 TMCD in the absence or presence of FLNa-Ig21. As previously reported 17 , we found that a dynamic equilibrium exists between free α IIb (or β 3 ) TMCD and α IIb TMCD complexed with β 3 TMCD ( Fig. 4d,e) . Remarkably, FLNa-Ig21 increased the population of the α IIb TMCD-β 3 TMCD complex in bicelles, as judged by the signal-intensity enhancement of the complex signal and the signal reduction of the free form ( Fig. 4d-f) , thus demonstrating the role of filamin in promoting integrin transmembrane heterodimerization by stabilizing the CT clasp.
FLNa-Ig21 mediates retention of inactive integrin
The combined biochemical and structural data indicate that FLNa-Ig21 stabilizes inactive integrin by favoring integrin CT-clasp formation. This is consistent with previous functional data in which transfection of integrin α IIb β 3 into CHO cells led to basal-level integrin activation, whereas cotransfection of FLNa-Ig21 with α IIb β 3 inhibited such integrin activation 6 . To gain functional evidence for this possibility, we performed a series of mutagenesis experiments. FLNa-Ig21 E2276A and A2268K mutations-which were expressed similarly as WT FLNa-Ig21 (Supplementary Fig. 4g ) but disrupted the FLNa-Ig21 interaction with the integrin α IIb and β 3 membrane-proximal helices, respectively (Supplementary Fig. 3a,e )-had reduced capacity in inactivating integrin as compared to that of wild type FLNa-Ig21 (Fig. 5a) . Interestingly, the α IIb (K994E R997E) mutation, which disrupts α IIb binding to FLNa-Ig21 (Supplementary Fig. 3c) , caused substantial constitutive enhancement of integrin α IIb (K994E R997E) β 3 activity as compared to that of the WT integrin (Fig. 5b) . Because endogenous filamin is likely to bind and stabilize inactive integrin, a r t i c l e s disrupting the filamin-α IIb CT interaction by this mutation would clearly destabilize the integrin CT clasp and shift the equilibrium to the active state of integrin, thus leading to the enhancement of integrin activation. Consistently with this interpretation, the PAC1 binding of the α IIb (K994E R997E)β 3 mutant was less inhibited (~20%) than WT integrin (~40%) by FLNa-Ig21 (Fig. 5b) . These functional data provide supporting evidence that FLNa-Ig21 mediates retention of integrin in an inactive state.
Multiple filamin repeats inhibit integrin activation
In addition to FLNa-Ig21, multiple repeats in filamin were previously found to bind integrin β CT 12 . This led us to wonder whether they function similarly to FLNa-Ig21. Just like FLNa-Ig21 (Fig. 1) , FLNa Igs 9, 12, 17 and 19 all bind to both α IIb CT and β 3 -N ( Supplementary  Fig. 5 ). FLNa-Ig4 is unstable 12 , thus preventing its precise measurement of binding to integrin CTs. Remarkably, FLNa Igs 9, 12, 17 and 19 all exerted the inhibitory effect on integrin activation (Fig. 5c) . FLNa-Ig4 did not have a significant effect, probably because of its structural instability or weaker binding to integrin. Interestingly, the small hydrophilic or positively charged region that may bind to the membrane, as shown in FLNa-Ig21 containing H2239, K2240 and R2242, is highly conserved among these repeats 12 . From biochemical and NMR data, we previously proposed that full-length filamin may locally enrich inactive integrins via multiple similar repeats 12 . Our data (Fig. 5c) provide functional evidence to support this mechanism, which may spatiotemporally favor integrins to bind multivalent ligands such as fibrinogen and fibronectin upon integrin activation.
DISCUSSION
Although emerging evidence has indicated the existence of integrin inactivators in dynamic regulation of integrin function 3 , the underlying molecular principle of these inactivators has remained elusive. In this study, we have succeeded in determining the NMR structure of FLNa-Ig21 bound to an integrin α IIb β 3 CT heterodimer. Our structure reveals that an inactivator may bind and stabilize an inactive integrin by stabilizing the integrin CT clasp, which is known to be crucial for restraining the resting-state integrin [13] [14] [15] [16] [17] [18] [19] . It was widely thought that inactive integrin could be purified in a fully naked state, but recent structural studies have revealed that purified integrin α IIb β 3 from resting-state platelets contains a subpopulation of active-state integrin probably reflecting the intrinsic conformational equilibrium between the inactive (bent) and active state (extended) of the integrin 20 . This was reflected in our activation assay ( Fig. 5a) , in which transiently expressed integrin α IIb β 3 exhibited basal-level PAC1 binding. The basal level of integrin activation is unlikely to be totally caused by talin because endogenous talin is supposed to be autoinhibited [21] [22] [23] and randomly distributed in unstimulated cells 24 .
Rather, we believe that the activation is at least partially caused by a subpopulation of transiently expressed naked active integrin that is in equilibrium with inactive integrin. Our interpretation is supported by several lines of evidence: (i) Inhibition of this activation by filamin probably shifts the equilibrium to the inactive state of integrin (Fig. 5a) . As shown before, the same assay does not reveal an inhibitory effect of filamin on the talin-mediated integrin activation 25 , probably because of the much higher affinity of talin binding to integrin and membrane than filamin. (ii) Specific point mutation in filamin, which disrupts its binding to the α IIb CT ( Supplementary  Fig. 4a,b ) without affecting talin binding to the β 3 CT, impaired the ability of filamin to inhibit integrin activation (Fig. 5a) . npg a r t i c l e s (iii) Point mutation in α IIb CT (K994E R997E), which disrupted the filamin-α IIb CT interaction but not the talin-β 3 CT interaction, enhanced constitutive integrin activation, and filamin had reduced capacity to inhibit the mutant integrin ( Fig. 5b) . Upon cellular stimulation, talin is known to rapidly localize to the plasma membrane 24 . By contrast, filamin is mostly situated near the plasma membrane in unstimulated cells, and it rapidly redistributes into the cytosol upon integrin activation 26 . Such reciprocal redistribution is consistent with our findings, thus supporting a model in which filamin stabilizes the integrin CT clasp to prevent spontaneous activation of the receptor in unstimulated cells, whereas cellular stimulation induces membrane targeting and unmasking of talin to bind and activate integrin. The membrane-localized talin in its active state may then activate integrin by directly competing with filamin. Such competition was previously suggested to occur at an overlapping binding site in the C terminus of the integrin β CT 4 . However, our structure suggests a crucial revision of this competition mechanism, whereby talin would compete with filamin for binding to both the C-terminal and membrane-proximal regions of β CT (comparison between Fig. 6a and Fig. 6b ). In addition to this talin-filamin competition pathway, other pathways may exist under certain cellular conditions. For example, migfilin, a cytoskeletal adaptor, was previously shown to bind filamin and displace it from integrin, thereby facilitating integrin activation 6, 12 . On the basis of our data, such displacement would destabilize the integrin CT clasp, thus favoring the equilibrium shift from the resting to the active state of the receptor. The displacement may further promote talin binding to the integrin β CT and induce integrin CT unclasping 13, 16 , thus leading to enhanced integrin activation. Interestingly, migfilin was shown to be recruited by kindlin 27 , a well-established integrin coactivator that also binds to the integrin β CT 2,3 . Mice with ablation of migfilin are viable, albeit with defects in migration 28 and bone remodeling 29 . It remains to be determined whether there exist additional filamin-binding proteins that may act similarly to migfilin to regulate integrin activation.
Lau et al. previously suggested that the membrane-proximal regions of α IIb β 3 CTs are embedded in the membrane in the absence of any regulators 17 . Using membrane-mimetic bicelles, the authors showed that α IIb membrane-proximal CT adopts a reverse turn that packs against the β 3 membrane-proximal CT helix 17 (Supplementary  Fig. 6a ). Such a structure is different from our filamin-bound α IIb β 3 CT complex, in which both α IIb and β 3 membrane-proximal regions adopt helical conformation and pack against each other (Supplementary Fig. 6b ). The structural difference may be because the α IIb β 3 TMCD structure by Lau et al. 17 was determined in the presence of bicelles lacking filamin, whereas ours was determined in a cytosolic condition containing filamin. Interestingly, our structure is similar to other structures previously determined in the cytosolic state 13 (Supplementary Fig. 6c ) and in organic solvent 19 in the absence of filamin (Supplementary Fig. 6d) , and our data demonstrated that filamin stabilizes these structures, notably the membrane-proximal CT clasp. It is clear that the membrane-proximal regions, if inserted into the membrane as suggested before 17 (Supplementary Fig. 6a) , would be inaccessible to filamin and possibly to other cytosolic integrin inactivators such as Sharpin 30 and CIB 31 . Indeed, our data showed that FLNa-Ig21 only weakly interacts with the membrane surface via polar interactions (Fig. 4a-c) , thus allowing the filamin interaction with the α IIb β 3 CT complex in the cytosolic state (Fig. 2) . The cytosolic engagement of filamin not only stabilizes the α IIb β 3 CT complex (Fig. 2) but further promotes the integrin transmembrane heterodimerization in membrane bicelles ( Fig. 4d-f) . Given that FLNa-Ig21 has only a weak polar interaction with the membrane surface instead of inserting into the membrane (Fig. 4b) , we conclude that in the filamin-stabilized inactive integrin heterodimer, the membrane-proximal regions of α IIb β 3 CTs are within the cytosol and are not buried in the membrane. It is possible that upon release of filamin by migfilin, talin or other potential regulators, these regions may find the hydrophobic environment of the membrane more favorable and insert into the membrane, thereby triggering conformational change and ultimate activation of integrin. Further investigation is clearly necessary to elucidate this possibility.
In summary, we have determined what is, to our knowledge, the first 3D structure of an integrin inactivator bound to the resting-state integrin αβ CT heterodimer. The structure suggests a new mechanism in which filamin favors retention of integrin in an inactive state. Such filamin-stabilized inactive integrin would prevent spontaneous integrin activation in resting cells and the pathological consequences of spontaneous integrin activation such as thrombosis and tumor metastasis 9 . It may also allow tight control of interconversion between the resting and active state of integrin, which is necessary for dynamic regulation of cyclic processes such as cell migration. Given that multiple filamin repeats bind and inhibit integrin ( Fig. 5c) , it is also possible that filamin clusters inactive integrins 12 and that the removal of filamin from clustered integrins may spatiotemporally promote their binding to multivalent ligands such as fibrinogen and fibronectin. Finally, although the structural mechanisms of other integrin inactivators such as Sharpin, CIB and MDG1 (refs. 2,3) remain to be determined, that they all bind to the membrane-proximal region of integrin CTs suggests that they may share a common binding mode favoring the conformation of the resting state of integrins and/or preventing the receptor binding to talin. Recent studies on Sharpin have provided excellent functional evidence for such a possibility 30 . It is our hope that more data will be reported in the near future, to allow a thorough understanding of how these integrin inactivators regulate the dynamic adhesion and migration of a variety of cells.
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